Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease

NCT04332991 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04332991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04332991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
April 2, 2020
Completion date
July 23, 2020
Enrollment
479 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, coronavirus, sars-cov infection